Gene: ADAMTS14
Official Full Name: ADAM metallopeptidase with thrombospondin type 1 motif 14provided by HGNC
Gene Summary: This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme cleaves amino-terminal propeptides from type I procollagen, a necessary step in the formation of collagen fibers. Mutations in this gene may be associated with osteoarthritis in human patients. [provided by RefSeq, May 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25546 | ADAMTS14 Knockout cell line (HCT 116) | Human | ADAMTS14 | 1:2~1:4 | Negative | Online Inquiry |
ADAMTS14 Gene Knockout Cell Lines are engineered cellular models designed to investigate the biological functions of the ADAMTS14 gene, which encodes a member of the disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family. This gene plays a crucial role in extracellular matrix remodeling and interacts with various skeletal and inflammatory processes. By utilizing CRISPR-Cas9 technology to create a targeted gene knockout, these cell lines facilitate the study of ADAMTS14's contributions to cellular behaviors such as migration, proliferation, and extracellular matrix turnover.
The key function of ADAMTS14 is its involvement in the degradation of specific matrix components, which influences tissue remodeling during development and disease. By creating a knockout, researchers can observe the phenotypic consequences of the gene's absence, allowing for deeper insights into its role in pathological conditions such as osteoarthritis and fibrosis. The precise elimination of ADAMTS14 provides an invaluable tool for exploring its pathways and interactions, ultimately assisting in the development of targeted therapeutic strategies.
In the realm of scientific research, the ADAMTS14 Gene Knockout Cell Lines serve a pivotal function. They are particularly valuable in elucidating mechanisms of diseases where ADAMTS14 is implicated, enabling clinicians and researchers to identify novel biomarkers or treatment targets. Unlike alternative models, which may not adequately recapitulate the absence of this specific gene, our knockout cell lines ensure high specificity and reproducibility.
Moreover, these cell lines offer distinct advantages including a faster experimental setup, reduced variability, and the convenience of working with immortalized cell lines, which are reproducible and readily available. Their comprehensive dataset supports hypothesis-driven studies, making them an indispensable asset for both academic and clinical laboratories focused on molecular biology and pathology.
Our company specializes in providing highly validated biological products that empower researchers in their quest for scientific breakthroughs. With our commitment to quality and innovative research tools like the ADAMTS14 Gene Knockout Cell Lines, we equip scientists with the resources needed to unlock new understandings in cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.